Better Tool to Predict Death After Cardiac Admission

New cardiac-specific tool or index was better at predicting death after cardiac admission than current indexes.

New tool designed for patients with heart disease is better at predicting death after hospital admission than the existing tools, according to a study published in CMAJ (Canadian Medical Association Journal).//

"This cardiac-specific //tool, or index, to predict death outperforms current general indexes used to predict death," says Dr. Marc Jolicoeur, Montreal Heart Institute, Université de Montréal, Montréal, Quebec.

‘New cardiac tool helps to identify risky heart patients earlier so that, appropriate care can be taken.’
Read More..

"The other available tools are good for all patients, but we developed one that is better specifically for cardiac patients."

Current indexes already exist to help predict likelihood of death and are widely used in clinical settings, although these are not disease-specific, and accuracy for patients with cardiac issues has not been widely investigated.

Researchers analyzed administrative data on cardiac patients admitted to the Montreal Heart Institute to create and test an index, the Cardiac-Specific Comorbidity Index, to help predict death both in-hospital and within one year in a group.

They then tested the index in a group of almost 19 000 cardiac patients in Alberta. Their cardiac-specific comorbidity index outperformed both the Charlson-Deyo comorbidity index and the Elixhauser comorbidity index.

"Estimating risk is important for patients and their families, as well as policy-makers, to help them monitor outcomes at various hospitals and guide decisions," says Dr. Jolicoeur.

Advertisements

Sudden Cardiac Deaths can Occur Any Day, Any Time
Why sudden cardiac deaths no longer peak on weekday morning? Stress is likely a major factor to explain why more cardiac arrests happen outside of previously identified peak times, stated study.

"With this tool, patients at high risk can be flagged, and appropriate care can be taken to manage their condition," he says.

Most importantly, this tool was derived and validated in Canada and will therefore be suitable for use by Canadian researches, administrators and decision-makers.